Mark Emalfarb
Founder bij DYADIC INTERNATIONAL, INC.
Vermogen: 6 M $ op 29-02-2024
Profiel
Mark A.
Emalfarb founded Dyadic International, Inc. Mr. Emalfarb is President, Chief Executive Officer & Director at this company and Chairman & Chief Executive Officer of Dyadic International (USA), Inc. (a subsidiary of Dyadic International, Inc.).
He is also on the board of Biotechnology Development For Industry In Pharmaceuticals SL.
Mr. Emalfarb received an undergraduate degree from the University of Iowa.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
DYADIC INTERNATIONAL, INC.
15.73% | 02-01-2024 | 4 532 493 ( 15.73% ) | 6 M $ | 29-02-2024 |
Actieve functies van Mark Emalfarb
Bedrijven | Functie | Begin |
---|---|---|
DYADIC INTERNATIONAL, INC. | Founder | 01-01-1979 |
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Chief Executive Officer | 05-10-2011 |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Director/Board Member | 13-09-2017 |
Opleiding van Mark Emalfarb
University of Iowa | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DYADIC INTERNATIONAL, INC. | Health Services |
Bedrijven in privébezit | 2 |
---|---|
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Health Technology |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Commercial Services |